title: Treatment of latent tuberculosis infections in the Darwin region.
authors.affiliation: Centre for Disease Control Department of Health, Darwin, NT rowena.boyd@nt.gov.au.
authors.forename: Rowena
authors.initials: R
authors.lastname: Boyd
authors.affiliation: Centre for Disease Control Department of Health, Darwin, NT.
authors.forename: Vanessa
authors.initials: V
authors.lastname: Johnston
authors.affiliation: Centre for Disease Control Department of Health, Darwin, NT.
authors.forename: Belinda
authors.initials: B
authors.lastname: Farmer
authors.affiliation: Centre for Disease Control Department of Health, Darwin, NT.
authors.forename: Vicki L
authors.initials: VL
authors.lastname: Krause
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007538:Isoniazid / Q000627:therapeutic use*; D055985:Latent Tuberculosis / Q000188:drug therapy*; D008297:Male; D055118:Medication Adherence; D008875:Middle Aged; D015876:Northern Territory; D016017:Odds Ratio; D012293:Rifampin / Q000627:therapeutic use; D044465:White People; D055815:Young Adult; D000095283:Australian Aboriginal and Torres Strait Islander Peoples
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin